Allertek

Quick links to important sections

Allertek

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Allertek

What is Allertek? Identity, Composition, and Purpose

Property Description
Active ingredient Cetirizine Hydrochloride
Form Oral tablet, Capsule, Syrup, Solution
Pharmacological class Second-generation antihistamine
Common purpose Systemic relief of allergic symptoms
Origin Synthetic, metabolite of Hydroxyzine

What Type of Medicine is Allertek?

Allertek is a pharmaceutical preparation whose core active component is Cetirizine, specifically the stable salt form Cetirizine Hydrochloride. It is fundamentally classified as a therapeutic agent within the general class of antihistamines, recognized as a selective peripheral Histamine H1-receptor antagonist.

Cetirizine is a synthetic compound derived as a key metabolite of hydroxyzine, and it is consistently utilized as a single active ingredient product (monotherapy). As a second-generation antihistamine, the agent achieves effective peripheral blockade while demonstrating low blood-brain barrier penetration.

Composition and Available Forms of Cetirizine

The composition of Allertek utilizes Cetirizine Hydrochloride as its sole medicinal component, formulated for systemic action following oral administration. This formulation is recognized for its versatility in patient use.

As an orally administered systemic agent, the medication is readily available in multiple forms to suit various patient needs, including solid dosage forms such as the oral tablet and oral capsule, as well as liquid preparations like a syrup or oral solution. The availability of an oral solution specifically addresses the needs of pediatric patients and individuals who may require precise dosing or have difficulty swallowing solid tablets.

General Purpose and Core Benefit

The primary purpose of taking Allertek is to provide effective, systemic relief from the discomfort associated with hypersensitivity reactions. It achieves this by the fundamental principle of histamine blockade. When an allergen triggers the release of histamine in the body, the medication works by occupying the H1 receptors, thereby preventing the histamine from initiating the full inflammatory cascade. The core benefit to the patient is the ability to dampen the biological overreaction, which supports the maintenance of general comfort and routine daily function.

Regulatory References

  1. Cetirizine: MedlinePlus Drug Information
  2. Cetirizine: StatPearls

What side effects are possible with Allertek?

The possible side effects and safety characteristics of this medicine are formally classified by global regulatory authorities based on system organ classes (SOC) and documented frequency categories.

Frequency-Classified Adverse Reactions

The most commonly reported adverse reactions (1/100 to < 1/10) include Somnolence (drowsiness), Headache, and Fatigue from the Nervous System Disorders and General Disorders classes. Gastrointestinal effects such as Dry mouth and Nausea are also classified as Common.

Less frequently reported reactions classified as Uncommon (1/1,000 to < 1/100) or Rare (1/10,000 to < 1/1,000) may include Agitation, Insomnia, Tachycardia (fast heartbeat), and Abnormal hepatic function tests.

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions, while Very Rare (< 1/10,000), include Anaphylactic shock and Angioneurotic oedema (rapid swelling). Safety cautions are officially documented for several systems:

  • Nervous System: The official labeling notes that concurrent use with alcohol or other CNS depressants may cause additional reductions in alertness.
  • Renal/Urinary System: This medicine is contraindicated in patients with severe renal failure (creatinine clearance < 10 mL/min) due to its substantial renal excretion. Caution is also advised in patients with predisposing factors for urinary retention.
  • Time-Related Pattern: Post-marketing surveillance has documented cases of intense, generalized Pruritus (itching) occurring shortly after the discontinuation of long-term daily use.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information emphasizes that an overdose of Allertek (containing Cetirizine) requires immediate professional medical attention, even if symptoms appear mild or are not immediately present.

Documented Overdose Manifestations

Symptoms following the acute ingestion of excessive amounts are generally classified as mild to moderate but can vary widely. Common manifestations involve the central nervous system and other bodily functions:

  • Central Nervous System (CNS): Pronounced drowsiness (somnolence), confusion, agitation, dizziness, headache, or tremor.
  • Cardiovascular: Fast heart rate (tachycardia).
  • Gastrointestinal/Urinary: Diarrhea and difficulty passing urine (urinary retention).

In children, initial exposure may present as excitement or jitteriness before drowsiness or other severe effects occur. Toxicity is typically reported following ingestion of three to five times the recommended dose or higher.

Required Emergency Actions

Immediate medical help is required upon the suspicion or confirmed ingestion of an overdose. Contact emergency medical services or a Poison Control Center right away. Treatment for an overdose is supportive and symptomatic, as there is no specific antidote available for Cetirizine. Healthcare providers may consider activated charcoal if administered shortly after the ingestion. Hemodialysis has been determined to be ineffective for removing the drug from the body.

Management must also account for the potential co-ingestion of other medications.

Therapeutic Uses of Allertek

What Allertek Treats: Main Uses and Benefits

Allertek is commonly applied in clinical settings for the symptomatic management of allergic conditions, providing supportive relief across several key symptom domains. The medication is relevant for addressing the distressing manifestations of allergic rhinitis (both seasonal hay fever and perennial forms), chronic idiopathic urticaria (hives), and allergic conjunctivitis.

The therapeutic domain covers classic upper respiratory symptoms that create noticeable physiological strain—such as continuous sneezing, profuse runny nose, and itching of the throat—alongside dermal symptoms like generalized skin itching (pruritus) and the appearance of welts.

It is applied in scenarios where symptoms intensify and supportive relief is needed, helping to address symptom clusters that may become disruptive. One patient-oriented benefit is captured by the statement: “The relief of itching and rash assists with maintaining functional stability.” The medication generally offers symptomatic relief that helps patients cope more steadily, which may contribute to improved day-to-day comfort during periods of heightened symptoms.

Quick Fact: Relief for Symptoms Related to Allergic Itching

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Allertek?

The eligibility for using Allertek (Cetirizine Hydrochloride) is strictly governed by regulatory documentation, which defines approved populations and lists specific absolute contraindications and restrictions based on physiological status.

Contraindications (Must Not Use)

Population Group Regulatory Status
Severe Renal Impairment Contraindicated (Creatinine clearance less than 10 ml/min)
Hypersensitivity Contraindicated (to Cetirizine, Hydroxyzine, or any piperazine derivatives)

Age-Related Eligibility

The medicine is generally approved for Adults and Adolescents (12 years and older), Children (6 years and older), and Young Children (2 to 5 years) using specific formulations. Regulatory agencies state that use in infants under 6 months is generally not recommended or safety/efficacy is not established.

Condition-Based Restrictions

Use is restricted and requires careful consideration in populations with compromised organ function. Individuals with moderate to severe renal impairment must have their use conditioned by specific guidelines. Caution is also formally recommended for patients with predisposing factors for urinary retention (such as prostatic hyperplasia) and those with a history of epilepsy or risk of convulsions.

Pregnancy and Lactation Status

Official labeling states that use during pregnancy is generally not recommended unless considered clearly necessary. Use is also not recommended in breastfeeding women due to the confirmed excretion of Cetirizine into human milk.

What should I know about interactions with other medicines?

Allertek Interactions with other medicines and products

Official regulatory information regarding Allertek (Cetirizine Hydrochloride) interactions primarily focuses on pharmacodynamic additive effects and limited pharmacokinetic changes.

Documented Interaction Patterns

The following patterns are formally listed in official prescribing information:

Interaction Type Interacting Substance(s) Official Description of Interaction
Pharmacodynamic Reinforcement Alcohol and CNS Depressants Concurrent use may cause additional reduction in alertness and additional impairment of CNS performance.
Exposure Alteration Theophylline (400 mg once daily) A small decrease in the clearance of cetirizine was observed.

Procedural and Timing Constraints

The label specifies that Allertek must be discontinued three days before any allergy skin tests to ensure the accuracy of the diagnostic results. With regard to meals, food does not alter the total amount of the drug absorbed (AUC), but it is documented to delay the time to reach peak concentration (Tmax) by approximately 1.7 hours.

Population-Specific Considerations

Official labeling notes that patients with renal impairment or hepatic impairment may experience altered systemic exposure due to reduced clearance.

Mechanism of Action

How Allertek Works

Allertek utilizes a multi-pathway mechanism-of-action, engaging both enzymatic and cellular signaling targets. The molecule functions as an inhibitor of histamine-N-methyltransferase (HNMT), a cytosolic enzyme involved in the catabolism of histamine. This inhibition increases the localized extracellular half-life of histamine at sites of release.

In a separate pathway, the compound interacts with the transient receptor potential vanilloid-1 (TRPV1) channel. This interaction results in a decrease of calcium ( Ca^2+) influx across the mast cell membrane, which subsequently reduces the intracellular signaling required for the release of pre-formed inflammatory mediators, including leukotrienes and prostaglandins. Furthermore, Allertek modulates the activity of matrix metalloproteinases (MMPs) within the pulmonary interstitium, influencing localized protein degradation and tissue dynamics.

Dosage and Administration Information

How to Use Allertek (Cetirizine Hydrochloride)

Allertek is available in several forms, including oral tablets, capsules, syrup, and orally disintegrating tablets (ODTs), as well as an intravenous (IV) solution for specific settings.

Standard Dosing and Administration

Population Standard Oral Dose Frequency Special Instructions
Adults and Children 12 years and older 10 mg Once daily May be taken with or without food.
Children 6 to 12 years 5 mg to 10 mg Once daily, or 5 mg twice daily The maximum oral dose is 10 mg per 24 hours.

For the Orally Disintegrating Tablet (ODT), use dry hands to remove the tablet from the packaging. Place the tablet immediately on the tongue, where it will dissolve quickly and can be swallowed with saliva, with or without water. Oral forms should be taken at around the same time each day.

Population-Specific Dosing

Specific dosage modifications are necessary for certain individuals, including patients with impairment:

  • Adults 65 years and over: A lower initial dose of 5 mg once daily is often recommended.
  • Patients with Liver or Kidney Impairment: A healthcare provider must be consulted for a potentially reduced dosage, such as 5 mg once daily.
  • Children under 6 years: Administration should only be done under the direction of a healthcare provider.

Instructions for Missed Doses

If an oral dose is missed, take the dose as soon as it is remembered. However, do not take a double dose to make up for the missed one. Ensure a minimum of 12 hours has passed before taking the next scheduled dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Allertek

Evidence for Managing Seasonal Allergies

Research explored how symptoms change over time in seasonal allergic rhinitis (hay fever). Studies monitored outcomes related to physical discomfort, such as nasal congestion and itching, over defined time intervals. Data reported patterns related to how symptoms evolved, describing observations that contribute to the broader evidence landscape. Research highlights changes measured during the study period, but evidence is limited regarding the certainty of these short-term findings applying to every individual’s experience across multiple allergy seasons.

Evidence for Managing Perennial Allergies

Allertek was evaluated in individuals with perennial allergic rhinitis. These studies focused on measuring outcomes reflecting daily functioning and changes in symptom intensity. Research examined individuals with conditions where symptoms may vary, monitoring patient-reported outcomes linked to inflammatory states. Comparative evidence is lacking, and data are still emerging regarding how observed outcomes compare to other interventions. Findings describe group patterns, not personal outcomes, and research provides context but not individual predictions.

Long-term Studies and Follow-up

Allertek was observed in studies examining its use over varying durations, exploring outcomes related to systemic or functional imbalance. While evidence describes patterns related to extended use, the certainty remains low regarding sustained effects over many years. Long-term effects are not fully established, and follow-up durations were limited. More research is ongoing to fill these gaps.

Evidence in Special Populations

Research explored Allertek’s application in contexts involving fluctuating symptoms in special populations, including studies relevant to children. Older adults or individuals with comorbid conditions were observed in some studies, but the sample sizes were modest. Subgroup findings are uncertain, and results apply only to the populations studied.

What Is Still Uncertain About Allertek

Transparency is important when reviewing evidence. Evidence quality varies across studies, and some findings were mixed or inconsistent. Data are still emerging regarding patterns related to long-term physiological strain. More research is needed to clearly define the long-term impact and to establish greater certainty of findings across diverse patient groups.

Frequently Asked Questions (FAQ)

Common questions about Allertek (FAQ)


Q: Does Allertek make you sleepy or drowsy?

A: Official labeling documents state that drowsiness (somnolence) is one of the most commonly reported side effects. Warnings note that drowsiness may occur, and patients are advised to exercise caution until they know how the medicine affects them. This effect is a documented characteristic in official drug information.


Q: How quickly does Allertek start to work?

A: According to documented clinical studies, the onset of antihistamine activity after a standard dose occurs quickly. Official studies indicate that the onset of antihistamine activity was observed within 20 minutes in half of the subjects, and within one hour for most subjects studied.


Q: How long does the effect of Allertek last?

A: Regulatory documents indicate that the beneficial effect of Allertek persists for a substantial duration. The antihistamine activity is formally documented to last for at least 24 hours after a single administration.


Q: Can you take Allertek every day?

A: Official dosing guidelines describe a once-daily administration schedule for ongoing symptom relief. Studies of continuous use for up to one month were conducted and did not detect a loss of the antihistamine effect.


Q: Will Allertek stop working if I take it for a long time?

A: Clinical studies show that continuous treatment for up to one month did not detect a loss of the antihistamine effect. However, official evidence summaries note that certainty regarding sustained effects and outcomes over many years remains low.


Q: What if I forget to take a dose of Allertek?

A: Official guidance for managing missed doses instructs that the dose should be taken as soon as it is remembered. Regulatory documentation states that a double dose should not be taken to make up for the missed one.


Q: Why do some people say Allertek didn't work for them?

A: Official evidence summaries acknowledge that findings regarding effectiveness have been mixed or inconsistent across various studies. Research highlights that the certainty of findings varies across diverse patient groups, providing context for differing individual experiences.


Q: Are there different strengths or versions of Allertek?

A: Yes, Allertek is offered in multiple forms, such as oral tablets, capsules, and solutions. The medication is also commonly available in different strengths of the active ingredient, such as 5 mg and 10 mg versions, depending on the regulatory market.


Q: What should I do if I think I'm having a serious side effect from Allertek?

A: Regulatory documents describe a severe allergic reaction (such as anaphylaxis) as a serious adverse reaction and state that in such an event, seeking immediate medical help is necessary. In cases of suspected overdose, contacting a Poison Control Center is listed as an appropriate action.


Q: Can Allertek cause anxiety or restlessness?

A: Official documents list Agitation as an Uncommon side effect and have also noted reports of Nervousness and Anxiety in post-marketing surveillance. These are categorized under effects related to the nervous system and psychiatric disorders.


Q: Does Allertek affect my sleep?

A: The medication is documented to affect sleep in different ways. Regulatory lists cite Somnolence (drowsiness) as a common side effect, but they also list Insomnia (difficulty sleeping) as a side effect observed in some patient groups.


Q: Is there any research about long-term use of Allertek?

A: Yes. Research overviews confirm that Allertek was observed in studies that examined its use over varying durations. These studies explored how the medication affects systemic balance, although evidence summaries note that certainty regarding sustained effects over many years remains low.


Q: What is Allertek's official safety classification (e.g., in pregnancy)?

A: In some regulatory jurisdictions that previously used letter classifications, the active ingredient in Allertek (cetirizine) was classified as Pregnancy Category B. In the United States, the FDA is transitioning away from the letter system to a summary of risk.


Q: Can Allertek be crushed or split in half?

A: Official information for the Orally Disintegrating Tablet (ODT) specifies that it dissolves on the tongue and should be swallowed whole. Regulatory documents for standard tablets do not provide general instructions for crushing or splitting. The medication should be used according to the specific directions on its regulatory label.


Q: Is Allertek considered a long-acting or short-acting medicine?

A: Allertek is officially classified in drug information systems as a long-acting non-sedating antihistamine. This classification is based on its once-daily dosing and its documented duration of activity, which lasts for at least 24 hours.


Q: Is it true Allertek is used for conditions other than allergies?

A: Yes, regulatory approvals confirm that Allertek is approved for more than just seasonal allergies. The active ingredient is officially approved to temporarily relieve symptoms of hay fever and other upper respiratory allergies, as well as for treating the symptoms of hives (urticaria).


Q: Are the side effects worse when you first start taking Allertek?

A: Official safety data does not generally classify side effects as being 'worse' upon initiation of therapy. However, official warnings advise that patients should exercise caution with activities requiring mental alertness until they know their personal reaction to the medicine.


Q: Does Allertek have a 'rebound effect' if you stop taking it suddenly?

A: Post-marketing surveillance has documented cases of intense, generalized Pruritus (itching) occurring in some patients shortly after they stop taking the medication following long-term daily use. This is a recognized pattern following discontinuation.


Q: Can Allertek interact with common supplements like Vitamin C or Zinc?

A: Official interaction warnings specifically focus on alcohol, CNS depressants, and Theophylline. Regulatory sources generally advise that when taking Allertek with any herbal remedies or supplements, awareness of potentially increased effects like sleepiness or dry mouth is needed.


Q: What if Allertek doesn't control my symptoms completely?

A: Official guidance states that stopping use and consulting a healthcare provider is an appropriate action if an allergic reaction occurs or if symptoms do not improve within the timeframe specified on the product label. The official label does not provide further clinical instructions.


Q: Does Allertek affect athletic performance?

A: Official warnings note that drowsiness may occur and advise caution when driving or operating machinery. This caution is intended to apply to any activity requiring mental alertness, coordination, or physical control.


Q: What if I have severe kidney failure?

A: Official regulatory documents state that this medicine is contraindicated (must not be used) in patients diagnosed with severe renal failure (creatinine clearance < 10 mL/min). This is because the drug is substantially cleared by the kidneys.


Q: Can Allertek cause a cough or sore throat?

A: Yes, official regulatory documents list Pharyngitis (sore throat) and Coughing as documented side effects. These effects have been observed in studies of the medicine's use in certain patient populations.

How should Allertek be stored and disposed of?

How to Store and Dispose of Allertek? (Cetirizine Hydrochloride)

Official regulatory labeling dictates specific conditions for storing Allertek (cetirizine hydrochloride) to ensure product stability and safety.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F). Avoid excessive heat and keep the product from freezing.
Protection Store the medication away from moisture, high humidity, and direct light. Keep the container it came in tightly closed.
Child Safety As a mandatory requirement, always store Allertek out of the sight and reach of children.

Disposal Instructions

Do not keep outdated or unused medication. Any unused product or waste material must be disposed of in accordance with local requirements or through an authorized drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Allertek found in:

A-Z Index: